DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 8901 - 8925 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID Gene Name ▲ UniProt ID
C0699885 Carcinoma of bladder VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0010701 Phyllodes Tumor VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0086981 Sicca Syndrome VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0011849 Diabetes Mellitus VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0017152 Gastritis VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0021051 Immunologic Deficiency Syndromes VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0005695 Bladder Neoplasm VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0205734 Diabetes, Autoimmune VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0409974 Lupus Erythematosus VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0022658 Kidney Diseases VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C3805278 Extrahepatic Cholangiocarcinoma VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0042164 Uveitis VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0030186 Paget Disease Extramammary VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0008312 Primary biliary cirrhosis VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0079731 B-Cell Lymphomas VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0036202 Sarcoidosis VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0017661 IGA Glomerulonephritis VTCN1 79679 V-set domain containing T cell activation inhibitor 1 Q7Z7D3
C0268398 Familial lichen amyloidosis XPNPEP2 7512 X-prolyl aminopeptidase 2 O43895
C0085215 Ovarian Failure, Premature XPNPEP2 7512 X-prolyl aminopeptidase 2 O43895
C0025322 Premature Menopause XPNPEP2 7512 X-prolyl aminopeptidase 2 O43895
C0027651 Neoplasms XPNPEP2 7512 X-prolyl aminopeptidase 2 O43895
C3494522 Hypergonadotropic Ovarian Failure, X-Linked XPNPEP2 7512 X-prolyl aminopeptidase 2 O43895
C0002994 Angioedema XPNPEP2 7512 X-prolyl aminopeptidase 2 O43895
C4552079 Premature Ovarian Failure 1 XPNPEP2 7512 X-prolyl aminopeptidase 2 O43895
C0279702 Conventional (Clear Cell) Renal Cell Carcinoma XPNPEP2 7512 X-prolyl aminopeptidase 2 O43895

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024